Yes , well done to JAK. And a timely reminder to keep it civil in the korereo as this is an open forum, and us older folk need to be setting a good example.
Printable View
Typical OCA ….todays market wrap….up,up,up and one down
Retirement village operators were stronger following news aged care provider Heritage Lifecare’s private equity owner entered into a $291m sale-and-leaseback arrangement with ASX-listed Centuria Capital. Ryman Healthcare rose 1.1% to $12.20, Summerset was up 0.8% at $12.95, and Arvida increased 0.5% to $1.95. Aged care provider Oceania Healthcare declined 0.8% to $1.31
Its been a disappointing year for shareholders. Started the year at $1.45 and after theoretically promising so much potential its ended up materially underperforming the NZX50. I am holding a moderate stake, (free carry), and hoping for better things in 2022 but not expecting any huge miracles.
End of another month and another year ..... and again SUM share price seems to do better than OCA's
last 12 months OCA down 8% and SUM up 9% ....so the line on the trend heads south
The trend can't continue for ever - that would mean OCA goes to zero lol
Glad I have heaps more SUM than OCA ..... shouldn't have got sucked in by all the hype over the years and inflection points etc etc ...... but at least ahead on OCA but 'diversification' in the sector has been costly
Don't worry OCA believers - you could be right if you see the chart as 2022 is surely the year for OCA to be a star
To be fair, for most of that time OCA have been making steady progress towards transforming their old business model and with regard to brownfield developments, that's come at quite a cost. I'm hoping for a decent year for OCA in 2022 but not expecting any miracles. 2023 and 2024 should see the Oceania snowball really starting to gather momentum.
Patient puppies will get a very good feed in due course.
It seems a little strange to me that on one hand according to market screener almost all the analysts have this as a BUY with an average target price of $1.64 https://www.marketscreener.com/quote...268/consensus/
and yet on the other it got no love from any broker in the coming years share competition.
Contrasting that with HGH which attracted a lot of love (4 picks) and yet the average analyst price target is just $2.19 https://www.marketscreener.com/quote...144/consensus/ compared to the closing price for the year of $2.52.
Go figure ?
Covid ‘allegedly’ in Everil Orr
https://home.nzcity.co.nz/news/article.aspx?id=346202
Dogs of the Dow is a popular strategy. For those that don't know, you buy a bunch of the worst performers for the year of the Dow and hope they outperform the index the following year.
OCA was a real dog last year. Maybe 2022 will see it barking and outperforming the NZX50 ? If not, I think as long as one takes a "dogged" approach to holding over the next few years these should bark very nicely at some stage.
https://www.nzherald.co.nz/nz/kiwis-...VGKXYGV5HEDPQ/
Not a relative of a resident in an independent unit, not a resident in an independent unit, not a staff member either... but a resident at Everil Orr rest home which Oceania owns.
This may be a little different.
Fingers'n toes crossed this doesn't get into other residents at the rest home.